United States · Platforms & data · Yahoo Finance

Madrigal Pharmaceuticals (MDGL) Stock May Be Below Fair Value Despite First Profit

Published by Yahoo Finance · United States 9 h ago

Madrigal Pharmaceuticals has gone from a relatively small specialist to a business with more than US$1b in annualised sales from its liver drug Rezdiffra, yet the share price has…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Seeking Alpha

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

MarketWatch

These stocks have soared the most today after the Democrats trounced Trump

MarketBeat

Neuronetics (NASDAQ:STIM) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

The Motley Fool

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Investing.com

Eversource Energy earnings on deck after Q2 miss, estimate cuts

CNBC